Six Years' Experience with Prostaglandin I2 Infusion in Elective Open Repair of Abdominal Aortic Aneurysm: A Parallel Group Observational Study in a Tertiary Referral Vascular Center

Annals of Vascular Surgery

Volumn 22, Issue 6, 2008, Pages 750-755

  Beirne, Chris ^a   Hynes, Niamh ^a   Sultan, Sherif ^a,b  

^a UNIVERSITY HOSPITAL GALWAY   (Ireland)

^b Galway Clinic   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; CREATININE; ILOPROST; LACTIC ACID; TINZAPARIN; UREA;

ABDOMINAL AORTA ANEURYSM; AGED; ANEURYSM SURGERY; ARTICLE; ARTIFICIAL VENTILATION; ATELECTASIS; BLOOD TRANSFUSION; BLOOD VESSEL DIAMETER; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE CLEARANCE; DIALYSIS; DRUG EFFECT; DRUG WITHDRAWAL; DUODENUM PERFORATION; ELECTIVE SURGERY; ENTEROPATHY; FEMALE; GASTROINTESTINAL HEMORRHAGE; GLOMERULUS FILTRATION; GROUPS BY AGE; HEART MUSCLE ISCHEMIA; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPOTENSION; INTENSIVE CARE UNIT; INVASIVE PROCEDURE; KIDNEY TUBULE NECROSIS; LACTATE BLOOD LEVEL; LENGTH OF STAY; LIMB; LUNG EDEMA; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; MORBIDITY; OBSERVATIONAL STUDY; PARALLEL DESIGN; PATIENT MONITORING; PERIPHERAL ISCHEMIA; PNEUMONIA; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PSEUDOMEMBRANOUS COLITIS; RESPIRATORY FAILURE; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; SURVIVAL TIME; TERTIARY HEALTH CARE; THROMBOCYTE COUNT; UREA BLOOD LEVEL;

AGED; AORTIC ANEURYSM, ABDOMINAL; DATABASES AS TOPIC; EPOPROSTENOL; FEMALE; GASTROINTESTINAL DISEASES; GLOMERULAR FILTRATION RATE; HUMANS; INFUSIONS, PARENTERAL; INTENSIVE CARE; ISCHEMIA; KIDNEY; LUNG; MALE; MYOCARDIAL ISCHEMIA; PLATELET AGGREGATION INHIBITORS; REGIONAL BLOOD FLOW; RESPIRATION, ARTIFICIAL; SURGICAL PROCEDURES, ELECTIVE; TIME FACTORS; TREATMENT OUTCOME; VASCULAR SURGICAL PROCEDURES; VASODILATOR AGENTS;

EID: 55249099596     PISSN: 08905096     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.avsg.2008.08.036     Document Type: Article

References (22)

1. Strauss W.L., and Edelman J.D. Prostanoid therapy for pulmonary arterial hypertension. Clin Chest Med 28 (2007) 127-142
2. Kramm T., Eberle B., Guth S., and Mayer E. Inhaled iloprost to control residual pulmonary hypertension following pulmonary endarterectomy. Eur J Cardiothorac Surg 28 (2005) 882-888
3. Krug S., Hammerschmidt S., Pankau H., Wirtz H., and Seyfarth H.J. Acute improved hemodynamics following inhaled iloprost in chronic thromboembolic pulmonary hypertension. Respiration 76 2 (2008) 154-159
4. de Donato G., et al. ILAILL Study Group. Acute limb ischemia in elderly patients: can iloprost be useful as an adjuvant to surgery? Results from the ILAILL study. Eur J Vasc Endovasc Surg 34 (2007) 194-198
5. Milio G., Corrado E., Genova C., et al. Iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis and the quality of life: a new therapeutic protocol. Rheumatology (Oxford) 45 (2006) 999-1004
6. Black C.M., Halkier-Sorensen L., Belch J.J.F., et al. Oral iloprost in Raynaud's phenomenon secondary to systemic sclerosis: a multicentre, placebo-controlled, dose-comparison study. Br J Rheumatol 37 (1998) 952-960
7. Sablotzki A., Czeslick E., Schubert S., et al. Iloprost improves hemodynamics in patients with severe chronic cardiac failure and secondary pulmonary hypertension. Can J Anaesth 49 (2002) 1076-1080
8. Gouny P., Gaitz J.P., and Vayssairat M. Acute hand ischemia secondary to intraarterial buprenorphine injection: treatment with iloprost and dextran-40: a case report. Angiology 50 (1999) 605-606
9. 2) analog, in severe peripheral arterial disease (PAD). In: Samuelsson B., Wong Y.K., and Sun F.F. (Eds). Advances in Prostaglandin, Thromboxane, and Leukotriene Research, vol. 19 (1989), Raven Press, New York 311-316
10. Bugiardini R., Galvani M., Ferrini D., et al. Effects of iloprost, a stable prostacyclin analog, on exercise capacity and platelet aggregation in stable angina pectoris. Am J Cardiol 58 (1986) 453-459
11. Kappa J.R., Fisher C.A., Todd B., et al. Intraoperative management of patients with heparin-induced thrombocytopenia. Ann Thorac Surg 49 (1990) 714-723
12. Sobel M., Adelman B., Szentpetery S., et al. Surgical management of heparin-associated thrombocytopenia. J Vasc Surg 8 (1988) 395-401
13. Kappa J.R., Horn M.K., Fisher C.A., et al. Efficacy of iloprost (ZK36374) versus aspirin in preventing heparin-induced platelet activation during cardiac operations. J Thorac Cardiovasc Surg 94 (1987) 405-413
14. Addonizio V.P., Fisher C.A., Kappa J.R., et al. Prevention of heparin-induced thrombocytopenia during open heart surgery with iloprost (ZK36374). Surgery 102 (1987) 796-807
15. Levin M., Nakhoul F., Keidar Z., et al. Acute oliguric renal failure associated with unilateral renal embolism: a successful treatment with iloprost. Am J Nephrol 18 (1998) 444-447
16. Elinav E., Chajek-Shaul T., and Stern M. Improvement in cholesterol emboli syndrome after iloprost therapy. BMJ 324 (2002) 268-269
17. 1 on human platelet function. J Lab Clin Med 109 (1987) 184-190
18. Krause W., and Krais T. Pharmacokinetics and pharmacodynamics of radio-labeled iloprost in elderly volunteers. Eur J Clin Pharmacol 32 (1987) 597-605
19. Hildebrand M., Krause W., Angeli P., et al. Pharmacokinetics of iloprost in patients with hepatic dysfunction. Int J Clin Pharmacol Ther Toxicol 28 (1990) 430-434
20. Swedberg K., Held P., Wadenvik H., et al. Central hemodynamic and antiplatelet effects of iloprost-a new prostacyclin analogue-in acute myocardial infarction in man. Eur Heart J 8 (1987) 362-368
21. Bugiardini R., Galvani M., Ferrini D., et al. Myocardial ischemia induced by prostacyclin and iloprost. Clin Pharmacol Ther 38 (1985) 101-108
22. Hildebrand M., Krause W., Fabian H., Koziol T., and Neumayer H.H. Pharmacokinetics of iloprost in patients with chronic renal failure and on maintenance haemodialysis. Int J Clin Pharmacol Res 10 (1990) 285-292